We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Gut Microbiota is an Impact Factor based on the Brain-Gut Axis to Alzheimer's Disease: A Systematic Review.
- Authors
Bin Zou; Jia Li; Rui-Xia Ma; Xiao-Yu Cheng; Rui-Yin Ma; Ting-Yuan Zhou; Zi-Qi Wu; Yao Yao; Juan Li
- Abstract
Alzheimer's disease (AD) is a degenerative disease of the central nervous system. The pathogenesis of AD has been explained using cholinergic, β-amyloid toxicity, tau protein hyperphosphorylation, and oxidative stress theories. However, an effective treatment method has not been developed. In recent years, with the discovery of the brain-gut axis (BGA) and breakthroughs made in Parkinson's disease, depression, autism, and other diseases, BGA has become a hotspot in AD research. Several studies have shown that gut microbiota can affect the brain and behavior of patients with AD, especially their cognitive function. Animal models, fecal microbiota transplantation, and probiotic intervention also provide evidence regarding the correlation between gut microbiota and AD. This article discusses the relationship and related mechanisms between gut microbiota and AD based on BGA to provide possible strategies for preventing or alleviating AD symptoms by regulating gut microbiota.
- Subjects
GUT microbiome; ALZHEIMER'S disease treatment; FECAL microbiota transplantation
- Publication
Aging & Disease, 2023, Vol 14, Issue 3, p694
- ISSN
2152-5250
- Publication type
Article
- DOI
10.14336/AD.2022.1127